TickerFacts.

Baxter International Inc (BAX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$6.10B
As of 2025-12-31
$6.18B
As of 2026-06-30
+1.2%
3-year compound annual growth
-6.9%
5-year compound annual growth
-3.7%
10-year compound annual growth
$9.12B2007-12-31: $7.01B2008-12-31: $6.29B2009-12-31: $7.42B2010-12-31: $6.80B2011-12-31: $6.83B2012-12-31: $6.98B2013-12-31: $8.49B2014-12-31: $8.16B2015-12-31: $8.87B2016-12-31: $8.28B2017-12-31: $9.11B2018-03-31: $9.06B2018-06-30: $8.83B2018-09-30: $9.09B2018-12-31: $7.87B2019-03-31: $7.59B2019-06-30: $7.80B2019-12-31: $7.91B2020-12-31: $8.73B2021-12-31: $9.12B2022-12-31: $5.89B2023-12-31: $8.47B2024-12-31: $7.02B2025-12-31: $6.10B$6.10B
2007-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$6.10B-13.1%2026-02-12, Balance as of period end
2024-12-31$7.02B-17.1%2026-02-12, Balance as of period end
2023-12-31$8.47B+43.6%2026-02-12, Balance as of period end
2022-12-31$5.89B-35.4%2025-02-21, Balance as of period end
2021-12-31$9.12B+4.5%2024-02-08, Balance as of period end
2020-12-31$8.73B+10.3%2023-02-09, Balance as of period end
2019-12-31$7.91Bn/a2022-02-23, Balance as of period end
2019-06-30$7.80Bn/a2020-03-17, Balance as of period end
2019-03-31$7.59Bn/a2020-03-17, Balance as of period end
2018-12-31$7.87Bn/a2021-02-11, Balance as of period end
2018-09-30$9.09Bn/a2020-03-17, Balance as of period end
2018-06-30$8.83Bn/a2020-03-17, Balance as of period end
2018-03-31$9.06Bn/a2020-03-17, Balance as of period end
2017-12-31$9.11B+10.0%2020-03-17, Balance as of period end
2016-12-31$8.28B-6.6%2019-02-21, Balance as of period end
2015-12-31$8.87B+8.7%2018-02-23, Balance as of period end
2014-12-31$8.16B-3.9%2017-02-23, Balance as of period end
2013-12-31$8.49B+21.6%2016-02-26, Balance as of period end
2012-12-31$6.98B+2.2%2015-02-26, Balance as of period end
2011-12-31$6.83B+0.5%2014-02-21, Balance as of period end
2010-12-31$6.80B-8.4%2013-02-21, Balance as of period end
2009-12-31$7.42B+17.9%2012-02-23, Balance as of period end
2008-12-31$6.29B-10.2%2011-02-23, Balance as of period end
2007-12-31$7.01Bn/a2010-02-23, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Baxter International Inc (BAX)2025-12-31$6.10B-13.1%
Solventum Corp (SOLV)2025-12-31$5.05B+70.6%
Boston Scientific Corp (BSX)2025-12-31$24.47B+11.2%
Becton Dickinson & Co (BDX)2025-09-30$25.39B-1.9%
ResMed Inc (RMD)2026-06-30$6.59B+10.3%
3M Co (MMM)2025-12-31$4.75B+21.9%
Stryker Corp (SYK)2025-12-31$22.42B+8.7%
Dexcom Inc (DXCM)2025-12-31$2.75B+30.6%
Medline Inc. (MDLN)2025-12-31$10.74Bn/a

Compare BAX, SOLV, BSX, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗